Sponsor Pipeline

Protara Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2/3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07480356 Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of… Bladder (Urothelial, Transitional Cell) Cancer Recruiting
Phase 2/3
NCT06910943 Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal… Choline Deficiency Recruiting
Phase 2
NCT05871970 Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic… Lymphatic Malformation Recruiting
NCT05951179 Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With… Non-muscle Invasive Bladder Cancer Recruiting
Disease Areas
Bladder Cancer (2)
Get alerts when Protara Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free